Your browser doesn't support javascript.
loading
Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis.
Aleskandarany, Mohammad A; Abduljabbar, Rezvan; Ashankyty, Ibraheem; Elmouna, Ahmed; Jerjees, Dena; Ali, Simak; Buluwela, Laki; Diez-Rodriguez, Maria; Caldas, Carlos; Green, Andrew R; Ellis, Ian O; Rakha, Emad A.
Affiliation
  • Aleskandarany MA; Division of Cancer and Stem Cells, Molecular Pathology Research Unit, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK. mohammed.aleskandarany@nottingham.ac.uk.
  • Abduljabbar R; Department of Pathology, Faculty of Medicine, Menoufia University, Al Minufiyah, Egypt. mohammed.aleskandarany@nottingham.ac.uk.
  • Ashankyty I; Department of Oncology, Azadi Teaching Hospital, Duhok, Kurdistan, 1014 AM, Iraq.
  • Elmouna A; Molecular Diagnostics and Personalised Therapeutics Unit, University of Ha'il, Ha'il, Saudi Arabia.
  • Jerjees D; Molecular Diagnostics and Personalised Therapeutics Unit, University of Ha'il, Ha'il, Saudi Arabia.
  • Ali S; Division of Cancer and Stem Cells, Molecular Pathology Research Unit, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.
  • Buluwela L; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Diez-Rodriguez M; Department of Surgery and Cancer, Imperial College London, London, UK.
  • Caldas C; Division of Cancer and Stem Cells, Molecular Pathology Research Unit, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.
  • Green AR; Centre for the Cambridge Experimental Cancer Medicine Centre (ECMC) and Cambridge Breast Cancer Research Unit, Cambridge, UK.
  • Ellis IO; Division of Cancer and Stem Cells, Molecular Pathology Research Unit, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.
  • Rakha EA; Division of Cancer and Stem Cells, Molecular Pathology Research Unit, School of Medicine, University of Nottingham and Nottingham University Hospitals NHS Trust, City Hospital Campus, Nottingham, NG5 1PB, UK.
Breast Cancer Res Treat ; 159(2): 215-27, 2016 Sep.
Article in En | MEDLINE | ID: mdl-27514395

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Androgen / Carcinoma, Ductal, Breast Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2016 Type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Receptors, Androgen / Carcinoma, Ductal, Breast Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Breast Cancer Res Treat Year: 2016 Type: Article Affiliation country: United kingdom